Nicole Graf

Dr. Nicole Graf


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Neurology Genetics
Verified
Journal Article
Open access
PDF file
LWLeigh B. Waddell
Leigh B. Waddell
SBSamantha J. Bryen
Samantha J. Bryen
BCBeryl B. Cummings
Beryl B. Cummings
ABAdam Bournazos
Adam Bournazos
FEFrances J. Evesson
Frances J. Evesson
SCSandra T. Cooper
Sandra T. Cooper
Objective To describe the diagnostic utility of whole-genome sequencing and RNA studies in boys with suspected dystrophinopathy, for whom multiplex ligation-dependent probe amplification and exomic parallel sequencing failed to yield a genetic diagnosis, and to use remnant normal DMD splicing in 3 families to define critical levels of wild-type dystrophin bridging clinical spectrums of Duchenne to myalgia. Methods Exome, genome, and/or muscle RNA sequencing was performed for 7 males with elevated creatine kinase. PCR of muscle-derived complementary DNA (cDNA) studied consequences for DMD premessenger RNA (pre-mRNA) splicing. Quantitative Western blot was used to determine levels of dystrophin, relative to control muscle. Results Splice-altering intronic single nucleotide variants or structural rearrangements in DMD were identified in all 7 families. Four individuals, with abnormal splicing causing a premature stop codon and nonsense-mediated decay, expressed remnant levels of normally spliced DMD mRNA. Quantitative Western blot enabled correlation of wild-type dystrophin and clinical severity, with 0%–5% dystrophin conferring a Duchenne phenotype, 10% ± 2% a Becker phenotype, and 15% ± 2% dystrophin associated with myalgia without manifesting weakness. Conclusions Whole-genome sequencing relied heavily on RNA studies to identify DMD splice-altering variants. Short-read RNA sequencing was regularly confounded by the effectiveness of nonsense-mediated mRNA decay and low read depth of the giant DMD mRNA. PCR of muscle cDNA provided a simple, yet informative approach. Highly relevant to genetic therapies for dystrophinopathies, our data align strongly with previous studies of mutant dystrophin in Becker muscular dystrophy, with the collective conclusion that a fractional increase in levels of normal dystrophin between 5% and 20% is clinically significant.

1 July 2017 in European Journal of Medical Genetics
Verified
Journal Article
Closed access
NMNatalia Murray
Natalia Murray
BHB. Hanna
B. Hanna
NGNicole Graf
Nicole Graf
HFHe Fu
He Fu
VMVeronneau Mylène
Veronneau Mylène
ARAnne Ronan
Anne Ronan

12 April 2022 in European Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
CPChen Pettit
Chen Pettit
RKRoshana Kanagaratnam
Roshana Kanagaratnam
FCFinbarr Coughlan
Finbarr Coughlan
NGNicole Graf
Nicole Graf
DHDeirdre Hahn
Deirdre Hahn
ADAnne Durkan
Anne Durkan
Kidney biopsy is part of the diagnostic workup of many children with renal disease. Traditionally, a perpendicular approach to the biopsy has been used, but more recently, some proceduralists have favoured a tangential approach. It is not clear if one technique is superior with regards to tissue adequacy or complication rates. In our centre, interventional radiologists (IR) use general anaesthetic and a tangential approach, whereas paediatric nephrologists (PN) use sedation and a perpendicular approach. We examined consecutive native kidney biopsies performed between January 2008 and December 2017 for adequacy (sufficient tissue for light and electron microscopy and immunofluorescence) and examined the electronic medical records for data regarding technique and complications. IR performed 72 (29%) of the 245 native kidney biopsies, obtaining more total glomeruli (median 39 vs 16, p < 0.001) and more glomeruli per tissue core (median 13 vs 8, p < 0.001) than PN. No differences in specimen adequacy were observed between the two groups (79% IR vs 81% PN, p = 0.75) and a diagnosis could be made in 99% and 94% respectively (p = 0.1). A statistically lower rate of peri-nephric haematoma (28% vs 42%, p = 0.04) was detected in the IR group, but there were no significant differences in other complications. One patient required a blood transfusion (PN) and another required surgical intervention for a perinephric haematoma (IR).Conclusion: IR obtained larger samples and number of glomeruli, but the overall adequacy for native kidney biopsies was good using both perpendicular and tangential techniques, with low rates of significant complications. What is Known:• Kidney biopsy is integral to the diagnostic work-up of many children with kidney disease.• Kidney biopsy is a safe procedure with well-established complications in a minority of children. What is New:• Interventional radiologists had higher biopsy yield than paediatric nephrologists, possibly due to the tangential approach.• Biopsy adequacy rates are high using both techniques and provided a diagnosis in over 95% of cases.

1 October 2025 in Molecular Systems Biology
Verified
Journal Article
Open access
MJMoonSun Jung
MoonSun Jung
VPValentina Poltavets
Valentina Poltavets
JSJoanna N Skhinas
Joanna N Skhinas
GTGabor Tax
Gabor Tax
AKAlvin Kamili
Alvin Kamili
MKMaria Kavallaris
Maria Kavallaris
Precision medicine for paediatric and adult cancers that incorporates drug sensitivity profiling can identify effective therapies for individual patients. However, obtaining adequate biopsy samples for high-throughput (HTP) screening remains challenging, with tumours needing to be expanded in culture or patient-derived xenografts, this is time-consuming and often unsuccessful. Herein, we have developed paediatric patient-derived tumour models using an engineered extracellular matrix (ECM) tissue mimic hydrogel system and HTP 3D bioprinting. Gene expression analysis from a neuroblastoma and sarcoma paediatric patient cohort identified key components of the ECM in these tumour types. Engineered hydrogels with ECM-mimic peptides were used to bioprint and create patient-specific tumouroids using patient-derived cells from xenograft models, and the approach was further confirmed on direct patient tumour samples. Bioprinted tumouroids from the PDX models recapitulated the genetic and phenotypic characteristics of the original tumours and retained tumourigenicity. HTP drug screening of these models identified individualised drug sensitivities. Our approach offers a timely and clinically relevant technology platform for precision medicine in paediatric cancers, potentially transforming preclinical testing across multiple cancer types.

28 February 2014 in BioTech
Verified
Journal Article
Open access
PDF file
ACAlbert Chetcuti
Albert Chetcuti
NMNicole Mackie
Nicole Mackie
STSiamak Tafavogh
Siamak Tafavogh
NGNicole Graf
Nicole Graf
THTony Henwood
Tony Henwood
DCDaniel Catchpoole
Daniel Catchpoole
Despite neuroblastoma being the most common extracranial solid cancer in childhood, it is still a rare disease. Consequently, the unavailability of tissue for research limits the statistical power of studies. Pathology archives are possible sources of rare tissue, which, if proven to remain consistent over time, could prove useful to research of rare disease types. We applied immunohistochemistry to investigate whether long term storage caused any changes to antigens used diagnostically for neuroblastoma. We constructed and quantitatively assessed a tissue microarray containing neuroblastoma archival material dating between 1950 and 2007. A total of 119 neuroblastoma tissue cores were included spanning 6 decades. Fourteen antibodies were screened across the tissue microarray (TMA). These included seven positive neuroblastoma diagnosis markers (NB84, Chromogranin A, NSE, Ki-67, INI1, Neurofilament Protein, Synaptophysin), two anticipated to be negative (S100A, CD99), and five research antibodies (IL-7, IL-7R, JAK1, JAK3, STAT5). The staining of these antibodies was evaluated using Aperio ImageScope software along with novel pattern recognition and quantification algorithms. This analysis demonstrated that marker signal intensity did not decrease over time and that storage for 60 years had little effect on antigenicity. The construction and assessment of this neuroblastoma TMA has demonstrated the feasibility of using archival samples for research.

15 April 2025 in Histopathology
Verified
Journal Article
Open access
EPE J Perlman
E J Perlman
FWF Webster
F Webster
KCKenneth Tou-En Chang
Kenneth Tou-En Chang
ACA Coulomb
A Coulomb
LGL Galluzzo
L Galluzzo
MRM Reyes‐Múgica
M Reyes‐Múgica
Tumours arising within the developing kidney of children vary widely in their histological appearance and outcome; optimal therapy requires accurate classification and staging. The two major paediatric cooperative groups provide different therapeutic protocols based on different staging and classification, initially developed to serve patients in North America and Europe, but also used in many other parts/regions of the world. The International Collaboration on Cancer Reporting (ICCR) has developed a structure whereby such complex information may be harmonised, and able to be applied to patients globally. An international expert panel consisting of paediatric pathologists and oncologists produced a set of items critical to cancer reporting and subjected these to review and discussion using the structured processes provided by the ICCR. A formal ICCR structure was assembled, and consensus surrounding elements and their application to different therapeutic protocols was developed. The data set underwent open international consultation. This resulted in the first international data set for Wilms tumour (WT) and other paediatric renal tumours, provided herein. The use of ICCR methods enables a full understanding of highly complex and often overlapping reporting elements by international experts, and the potential of developing a set of commonly applied data elements that are fully defined. This sets the groundwork for future consolidation of definitions and harmonisation of therapies for WT and other paediatric renal tumour patients. It also allows institutions outside the major paediatric cooperative groups to provide therapy based on known elements.